MACSF

COMMUNIQUÉS West-GlobeNewswire

Adial Pharmaceuticals Files PCT Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to at least 2045
09/07/2025
Application Update Based on Extensive Review of Data GLEN ALLEN, Va., July 09, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. ( NASDAQ: ADIL ) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company [...]
Silexion Therapeutics Announces Positive Results in Preclinical Study Demonstrating Significant SIL204 Efficacy in Human Lung Cancer Cell Lines
09/07/2025
Company’s New Groundbreaking Preclinical Data in NSCLC Models Provides Further Validation for SIL204's Innovative Delivery System; Company is Currently Conducting Additional Studies into New and Previously Untested KRAS [...]
Moleculin Expands Phase 3 MIRACLE Clinical Trial into the Country of Georgia, Enrollment Update and Future Plans
09/07/2025
Secured approval from the Regulation Agency for Medical and Pharmaceutical Activities (RAMPA) in Georgia for Phase 2B/3 MIRACLE trial Recent EU approval from the European Medicines Agency (EMA) boosts trial profile [...]
Qanatpharma, Zuse Institute Berlin, Enamine, and Proteros biostructures Announce Generative-AI Driven Lead Discovery Collaboration
09/07/2025
Joint research program targets new treatments for life-threatening complication of brain hemorrhage An international discovery collaboration is harnessing AI-powered drug discovery to develop a first-in-class therapy to [...]
Palisade Bio Appoints Emil Chuang, MB BS FRACP to its Board of Directors
09/07/2025
Veteran clinical leader with successful track record and experience to help guide the Company’s clinical strategy in Fibrostenotic Crohn’s Disease and Ulcerative Colitis Carlsbad, CA, July 09, 2025 (GLOBE NEWSWIRE) -- [...]
Dandy Launches America’s First Two-Visit Dentures for Medicaid, Medicare, and Low-Paying PPOs
09/07/2025
Top-quality dentures. Affordable by design. Delivered in two appointments NEW YORK, July 09, 2025 (GLOBE NEWSWIRE) -- Dandy , America’s fully digital dental lab, today announced the first premium denture solution priced [...]
Connect Biopharma’s Exclusive Licensee in China, Simcere Pharmaceutical, Announced Submission of its New Drug Application for Rademikibart for the Treatment of Atopic Dermatitis in China
09/07/2025
SAN DIEGO, July 09, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”, “Connect”, or the “Company”), a clinical-stage biopharmaceutical company focused on transforming care [...]
INVO Fertility Enhances INVOcell Technology with Expanded Awareness, Training, and Improved Pricing
09/07/2025
SARASOTA, Fla., July 09, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare company focused on the fertility market, today announced further efforts to drive [...]
FDA Clears Updated Magstim Rapid Transcranial Magnetic Stimulation Research System
09/07/2025
Top-Cited TMS Brain Research Technology Enhanced for Next-Generation Neuromodulation MINNEAPOLIS, July 09, 2025 (GLOBE NEWSWIRE) -- The FDA has cleared the new Magstim Rapid TMS system for research and clinical [...]
FDA Grants Fast Track Designation for TRE-515 in Combination with Radiation Therapy for the Treatment of Metastatic Castration Resistant Prostate Cancer
09/07/2025
LOS ANGELES, July 09, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, announced today that [...]
A Life Rewritten: KFSHRC Treats Rare Disease After 22 Years of Specialized Care
09/07/2025
RIYADH, Saudi Arabia, July 09, 2025 (GLOBE NEWSWIRE) -- In a rare example of a lifelong bond between a patient and a healthcare institution, King Faisal Specialist Hospital & Research Centre (KFSHRC) in Riyadh has [...]
Bavarian Nordic Enters New Smallpox/Mpox Vaccine Supply Contract with European Country
09/07/2025
Recurring order from an undisclosed European country to strengthen public preparedness. Combined with other recent orders from non-European countries, the Company has now secured above DKK 3,000 million in contracts in [...]
Vireo Growth Inc. Completes Loan Refinancing and Upsize With a Bank Led Syndicate
08/07/2025
-- Company completes refinancing of all existing senior secured debt through a $120 million self-syndicated term loan with leading banks, at an interest rate of 8.3% -- -- Company also completes expansion of its [...]
Regal Medical Group, Lakeside Community Healthcare and ADOC Medical Group Add RadNet’s AI-Powered Enhanced Breast Cancer Detection (EBCD) Program to its Membership Benefits in Southern California
09/07/2025
Program will increase access to cutting-edge AI-powered breast cancer detection and is designed to boost compliance with annual cancer-screening guidelines Regal Medical Group, Lakeside Community Healthcare and ADOC [...]
Inside information: Orion upgrades full-year outlook for 2025
09/07/2025
ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION 9 JULY 2025 at 13.00 EEST Inside information: Orion upgrades full-year outlook for 2025 Orion Corporation upgrades the full-year outlook for 2025 both for [...]
Verrica Pharmaceuticals Reports Strong Growth in YCANTH® Dispensed Applicator Units in 2Q 2025
09/07/2025
– Company reports sequential quarterly growth of 32.8% over Q1 2025 with a record 13,434 YCANTH ® dispensed applicator units in Q2 2025 – – Company reports receipt of $8 million milestone payment from its Japanese [...]
BioCryst to Highlight Patient-focused Research at the 2025 US HAEA National Summit
09/07/2025
RESEARCH TRIANGLE PARK, N.C., July 09, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present new findings from patient-focused research highlighting the [...]
InspireMD Announces U.S. Commercial Launch of CGuard® Prime Carotid Stent System for the Prevention of Stroke
09/07/2025
MIAMI, July 09, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard Prime carotid stent system for the prevention of stroke, today announced the official commercial launch of the CGuard [...]
Arvinas Announces Retirement of Chief Executive Officer and Succession Plan
09/07/2025
– John Houston, Ph.D., Chairperson, CEO and President at Arvinas, Announces Plans to Retire as CEO Upon Appointment of Successor – – Dr. Houston to Remain Chairperson of Arvinas Board of Directors – – Arvinas Board of [...]

Pages